Could earlier testing for pregnancy diabetes prevent complications?

NCT ID NCT03523143

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This trial investigates whether screening for gestational diabetes earlier in pregnancy (at 18-20 weeks instead of the usual 24-28 weeks) and providing prompt lifestyle advice and medication if needed can reduce complications such as large babies, C-sections, and high blood pressure. About 2,000 pregnant women in Taiwan are taking part, with half receiving early screening and half receiving standard care. The study compares outcomes for both mothers and babies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
early screening and lifestyle intervention
What this could lead to
If early screening proves better, it could reduce complications like large babies, C-sections, and high blood pressure in pregnancy.
What could go wrong
This is a single-country trial, and early screening may not improve outcomes enough to change practice. Some women may receive unnecessary treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS IN PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Internal Medicine, National Taiwan University Hospital

    Taipei, Taiwan, 100, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.